Editorial
 LANDMARK DECISION ON ASR   
 Monday, December 10, 2018 
 In a landmark decision, the Union Health Ministry on November 29 this year approved a formula for determination of compensation for patients who had received faulty Articular Surface Replacement (ASR) hip implants manufactured by DePuy International Ltd, UK, a subsidiary of Johnson & Johnson (J&J). 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]NIH to fund HIV care and prevention research in vulnerable southern US communities
17:20  [IST]India set to attain SDG target for maternal and child health before 2030 deadline: PM
17:10  [IST]Nearly 30 million sick and premature newborns in dire need of treatment every year
17:00  [IST]Amgen, Magellan Rx collaborate to improve patient care for chronic, difficult-to-treat conditions
16:40  [IST]National Cradle Conference 2018 focuses on advance and extended care for mother and child
16:30  [IST]PHE report shows preventable illness is factor in slower life expectancy increases
more news >>
TOP NEWS
08:00  [IST]MAPPM to begin indefinite hunger strike from next month to protest against running of path labs by persons with DMLT
08:00  [IST]Haryana govt declares post of chief pharmacist as Class II officer, 38 CPs get gazetted rank
08:00  [IST]SKCDA wants all erstwhile Ranbaxy product distributors to supply medicines to Sun Pharma India distributors
08:00  [IST]IPC to organise workshop on 'Human Vaccines & Immunosera: Regulatory and Quality Considerations' on Dec 19 in Hyderabad
08:00  [IST]Hospital sector continues to face rough weather, ICRA study
08:00  [IST]Five-year Indo-US funding programme to help boost tuberculosis research; DBT, NIH to pool resources
more news >>
YESTERDAY'S NEWS
18:22  [IST]South Asia's largest pharma event CPhI and P-MEC India gets underway in Delhi
18:00  [IST]Axovant announces positive results from phase 2 study of nelotanserin in LBD patients with REM sleep behaviour disorder
17:55  [IST]Hinduja Healthcare Surgical receives TAVI accreditation
17:50  [IST]Nayati Healthcare partners with Sunder Lal Jain Hospital to improve healthcare delivery
17:40  [IST]Portea Medical forays into specialized & critical care services
17:30  [IST]Determined effort needed to eliminate unacceptably high rate of tuberculosis in India
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
ipc_2018
BTS_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |